Yang Yang, Zhang Song, Fan Chongxi, Yi Wei, Jiang Shuai, Di Shouyi, Ma Zhiqiang, Hu Wei, Deng Chao, Lv Jianjun, Li Tian, Nie Yongzhan, Jin Zhenxiao
a Department of Cardiovascular Surgery, Xijing Hospital , The Fourth Military Medical University , Xi'an , China.
b Department of Biomedical Engineering , The Fourth Military Medical University , Xi'an , China.
Expert Opin Ther Targets. 2016;20(5):519-31. doi: 10.1517/14728222.2016.1153067. Epub 2016 Mar 9.
Previous studies have verified that silent information regulator 1 (SIRT1), a class III histone deacetylase, protects against ischemia reperfusion (IR) injury (IRI) in some organs. In this study, we examined whether SIRT1 could protect against hepatic IRI and explored the potential mechanisms.
We examined whether SIRT1 could protect against hepatic IRI in vivo and in vitro using hepatic-specific SIRT1(-/-) mice, SIRT1 siRNA-transfected hepatocytes and SIRT1(+/+) hepatocytes.
The expression and activity of SIRT1 were significantly reduced during reperfusion compared with that observed in the control group. Hepatic-specific SIRT1(-/-) mice exhibited significant increase of hepatic damage markers and augment of oxidative stress and inflammatory response compared with control mice. In vitro studies demonstrated similar results. Furthermore, SIRT1 upregulation protects against hepatic IRI, through the overexpression of p-JNK, p-p38MAPK, and p-ERK. The protection of SIRT1 can be effectively reversed by the inhibitors of p38MAPK, JNK, and ERK.
The activation of SIRT1 significantly inhibits the oxidative stress and inflammatory response during hepatic IRI, which can be developed as a novel method to protect against hepatic IRI.
先前的研究已证实,Ⅲ类组蛋白去乙酰化酶沉默信息调节因子1(SIRT1)可保护某些器官免受缺血再灌注(IR)损伤(IRI)。在本研究中,我们检测了SIRT1是否能保护肝脏免受IRI损伤,并探讨了其潜在机制。
我们使用肝脏特异性SIRT1(-/-)小鼠、转染了SIRT1 siRNA的肝细胞和SIRT1(+/+)肝细胞,在体内和体外检测SIRT1是否能保护肝脏免受IRI损伤。
与对照组相比,再灌注期间SIRT1的表达和活性显著降低。与对照小鼠相比,肝脏特异性SIRT1(-/-)小鼠的肝脏损伤标志物显著增加,氧化应激和炎症反应增强。体外研究也得到了类似的结果。此外,SIRT1上调通过p-JNK、p-p38MAPK和p-ERK的过表达来保护肝脏免受IRI损伤。SIRT1的保护作用可被p38MAPK、JNK和ERK的抑制剂有效逆转。
SIRT1的激活显著抑制肝脏IRI期间的氧化应激和炎症反应,这可发展为一种保护肝脏免受IRI损伤的新方法。